Objectives

After participating in this educational activity, attendees should be able to:
1. Review recent changes in the definition and diagnosis of pulmonary hypertension
2. Discuss emerging therapies to treat pulmonary hypertension

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

Faculty
Mary Jo Farmer, MD, PHD, FCCP
Pulmonary and Critical Care Division, Baystate Health

Assistant Professor - UMMS - Baystate
 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.   

None of the faculty  for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

Planning Committee Member Dr. Skiest receives grant/research support through  GlaxoSmith Kline and Viiv     

 

Session date: 
Wednesday, November 25, 2020 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.